Media Releases

2021

10/06/2021

CCO and CFO appointed to bolster executive team

18/05/2021

Proteomics secures major analytical services contract

13/05/2021

Study demonstrates major economic health benefit of PromarkerD – PromarkerD reimbursement update

29/04/2021

Proteomics International files US FDA 513(g) regulatory submission

23/04/2021

Proteomics International achieves ISO 13485 certification

08/02/2021

Proteomics International seeks FDA approval for PromarkerD

2020

12/11/2020

Middle East is next market for PromarkerD immunoassay test

05/11/2020

PromarkerD clinical assay performance results published

23/10/2020

Proteomics International raises $6m in heavily oversubscribed Placement

16/10/2020

First distribution agreement for PromarkerD immunoassay

12/10/2020

PromarkerD international validation study results published

09/10/2020

Partnership with QIMR Berghofer targets oesophageal cancer

27/07/2020

PromarkerD Intellectual Property portfolio expands

15/06/2020

Big pharma clinical study validates PromarkerD kidney test

25/05/2020

Proteomics International receives COVID-19 research grants

1
2
3
4
5
6
7
8